| Literature DB >> 7997708 |
D M Finkelstein1, D A Schoenfeld.
Abstract
A primary endpoint of AIDS trials is the length of survival. Often there is auxiliary information available on measures of disease progression, which significantly alter the risk of mortality. This paper explores the use of this information in obtaining a refined estimate of survival, and a test based on this estimate. The methods are applied to an AIDS clinical trial, and results of simulations are provided which compare the approach to standard methods for survival analysis.Entities:
Mesh:
Year: 1994 PMID: 7997708 DOI: 10.1002/sim.4780131706
Source DB: PubMed Journal: Stat Med ISSN: 0277-6715 Impact factor: 2.373